| http://www.w3.org/ns/prov#value | - The present invention also relates to a pharmaceutical composition comprising trimegestone in a quantity of more than 500 ??g, preferably of at least 750 ??g, still more preferably of at least 1,000 ??g, most preferably of at least 2,000 ??g and in particular of at least 3,000 ??g, in combination with ethinyloestradiol in a quantity of preferably at least 5 ??g.
|
